One giant commercial leap for cell & gene therapies
Formulate, scale and standardize out-of-this-world launch strategies to bring your C&GTs to market fast and effectively
To succeed commercially in the US cell and gene market, pharma and biotech need to navigate through a meteor shower of risky unknowns, firsts, and new and complex partnerships. They must do this by formulating a launch strategy that engages the right commercial resource early on, rewrites traditional payment models in partnership with payers, and provides an integrated delivery network that scales up seamlessly, end-to-end.

At Reuters Events Cell & Gene Therapy 2021 (September 28-29, online), you will receive key lessons learned from those who have already achieved lift off. C-suite, commercial strategy, manufacturing and supply, pricing and access experts will provide you with the tools to launch successfully, sustain and scale your cell and gene therapy delivery in to hyperdrive.
Download the agenda and speaker line up to see how your launch strategy hold up >>>  
Speakers include: 
Download the Cell & Gene Therapy 2021 info pack now >>>  
Review our changemaking speaker line-up and expert-led agenda – download the Cell & Gene Therapy 2021 info pack now >>>  
Download your info pack now to learn more >>>  
Kind regards,
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.

Join us at Cell & Gene Therapy 2021 to achieve lift off with your C&GT pipeline: 

Fill in your details below to see the full agenda and speaker line up

Reuters Events will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy: